# Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects

> **NCT00608959** · PHASE3 · COMPLETED · sponsor: **Cadence Pharmaceuticals** · enrollment: 30 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** omiganan 1% gel
- **DRUG:** chlorhexidine 2% solution

## Key facts

- **NCT ID:** NCT00608959
- **Lead sponsor:** Cadence Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608959, "Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00608959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*